1 – 11 of 11
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with altered levels of proteins previously linked to inflammation, metabolism and cardiovascular disease
(
- Contribution to journal › Article
-
Mark
Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden
(
- Contribution to journal › Article
-
Mark
Plasma levels of per- and polyfluoroalkyl substances (PFAS) and cardiovascular disease – Results from two independent population-based cohorts and a meta-analysis
(
- Contribution to journal › Article
- 2018
-
Mark
Prenatal Bisphenol A Exposure is Linked to Epigenetic Changes in Glutamate Receptor Subunit Gene Grin2b in Female Rats and Humans
(
- Contribution to journal › Article
- 2008
-
Mark
Guidelines for radioiodine therapy of differentiated thyroid cancer
(
- Contribution to journal › Scientific review
- 2005
-
Mark
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis
(
- Contribution to journal › Scientific review
- 2004
-
Mark
Risk of Myocardial Infarction and Stroke in Smokers Is Related to Plasma Levels of Inflammation-Sensitive Proteins.
(
- Contribution to journal › Article
- 2002
-
Mark
Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men.
(
- Contribution to journal › Article
-
Mark
Long-term effects of inflammation-sensitive plasma proteins and systolic blood pressure on incidence of stroke.
(
- Contribution to journal › Article
-
Mark
Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins.
(
- Contribution to journal › Article
- 1999
-
Mark
Increasing plasma fibrinogen, but unchanged levels of intraplatelet cyclic nucleotides, plasma endothelin-1, factor VII, and neopterin during cholesterol lowering with fluvastatin
(
- Contribution to journal › Article